Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

AZ speeds first-line lung cancer filing for Tagrisso to EMA

AZ speeds first-line lung cancer filing for Tagrisso to EMA AZ describes Tagrisso as a third-generation EGFR inhibitor, with advantages over first-line agents - its own Iressa (gefitinib) product and Roche's Tarceva (erlotinib) - not only in efficacy but also ... In FLAURA, the median duration of response was

Prospects for Lilly’s Verzenio hit by botched lung cancer trial

Prospects for Lilly’s Verzenio hit by botched lung cancer trial The study compared Verzenio to Roche’s EGFR inhibitor Tarceva (erlotinib), which when it started in 2015 was the only agent indicated for second- and third-line therapy in advanced NSCLC,

AZ starts pursuit of lung cancer indication for Imfinzi

AZ starts pursuit of lung cancer indication for Imfinzi In that study, patients on Tagrisso had a PFS of 18.9 months, compared to just over 10 months for first-generation EGFR-targeting drugs, Roche's Tarceva (erlotinib) and

AZ buoyed by latest lung cancer data at ESMO

AZ buoyed by latest lung cancer data at ESMO to just over 10 months for first-generation EGFR-targeting drugs, Roche's Tarceva (erlotinib) and AZ's own Iressa (gefitinib).

AZ gets rapid approval in China for Tagrisso

AZ gets rapid approval in China for Tagrisso Moreover, nearly two thirds patients whose disease progresses after treatment with a first-line EGFR inhibitor - such as Iressa, Roche/Astellas' $2bn-a-year Tarceva (erlotinib) and Boehringer Ingelheim's Giotrif

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics